ANI Pharmaceuticals Inc (ANIP)
65.41
-0.68
(-1.03%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
0.00 (0.00%)
After-Hours: 20:00
ANI Pharmaceuticals Revenue (TTM): 486.82M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 486.82M |
| September 30, 2023 | 449.39M |
| June 30, 2023 | 401.39M |
| March 31, 2023 | 358.69M |
| December 31, 2022 | 316.38M |
| September 30, 2022 | 283.08M |
| June 30, 2022 | 251.32M |
| March 31, 2022 | 226.09M |
| December 31, 2021 | 216.14M |
| September 30, 2021 | 212.46M |
| June 30, 2021 | 213.38M |
| March 31, 2021 | 213.22M |
| December 31, 2020 | 208.48M |
| September 30, 2020 | 199.19M |
| June 30, 2020 | 197.55M |
| March 31, 2020 | 203.43M |
| December 31, 2019 | 206.55M |
| September 30, 2019 | 215.70M |
| June 30, 2019 | 215.07M |
| March 31, 2019 | 207.98M |
| December 31, 2018 | 201.58M |
| September 30, 2018 | 191.74M |
| June 30, 2018 | 189.20M |
| March 31, 2018 | 186.70M |
| December 31, 2017 | 176.84M |
| Date | Value |
|---|---|
| September 30, 2017 | 167.76M |
| June 30, 2017 | 158.12M |
| March 31, 2017 | 144.70M |
| December 31, 2016 | 128.62M |
| September 30, 2016 | 108.45M |
| June 30, 2016 | 89.90M |
| March 31, 2016 | 78.08M |
| December 31, 2015 | 76.32M |
| September 30, 2015 | 79.32M |
| June 30, 2015 | 76.74M |
| March 31, 2015 | 63.87M |
| December 31, 2014 | 55.97M |
| September 30, 2014 | 45.46M |
| June 30, 2014 | 35.91M |
| March 31, 2014 | 35.42M |
| December 31, 2013 | 24.66M |
| September 30, 2013 | 16.10M |
| June 30, 2013 | 8.375M |
| March 31, 2013 | 2.332M |
| December 31, 2012 | 2.301M |
| September 30, 2012 | 0.4475M |
| June 30, 2012 | 0.5199M |
| March 31, 2012 | 0.4922M |
| December 31, 2011 | 0.4352M |
| September 30, 2011 | 0.4638M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
197.55M
Minimum
Jun 2020
486.82M
Maximum
Dec 2023
267.07M
Average
215.70M
Median
Sep 2019
Revenue (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 131.31M |
| ADMA Biologics Inc | 258.22M |
| Dentsply Sirona Inc | 3.965B |
| Allogene Therapeutics Inc | 0.095M |
| Vanda Pharmaceuticals Inc | 192.64M |